| 1 | 1/1 | 返回列表 |
| 查看: 463 | 回復(fù): 0 | |||
[交流]
POSTDOCTORAL POSITION IN NEUROSCIENCE
|
|
The Song Lab at University of Pennsylvania/Children’s Hospital of Philadelphia is seeking creative and dedicated individuals with a strong passion for research, curiosity and self-motivation. Our lab offers an exciting opportunity to work in a closely collaborative, inspiring and dynamic environment. The long-term goal of the Song lab is to elucidate the cellular and molecular basis governing the formation, maintenance and function of neural circuits under physiological and pathological conditions. We are particularly interested in understanding how nervous system copes with injury and are developing strategies to promote neuroregeneration. We have established Drosophila injury models, are performing genetic screens to identify pathways regulating regeneration, are testing the evolutionary conservation of the novel regeneration regulators combining with mammalian injury models, and focus on targeting both the intrinsic and extrinsic mechanisms. With a background in neural development, neural circuits and behavior, fly and mouse genetics, injury and neurodegeneration, and tumor models, our lab offers a unique skillset to achieve this goal. Our lab is focused on three main themes: 1. Elucidating the mechanisms underlying neural degeneration and regeneration 2. Developing fly models for studying human neurodevelopmental disorders 3. Developing fly models for studying tumorigenesis Visit our lab website for more details https://songlab.research.chop.edu. Here is a shortlist of our recent publications: 1. Li D*#, Wang Q*, Gong NN, Kurolap A, Feldman HB, Boy N, Brugger M, Grand K, McWalter K, Sacoto MJG, Wakeling E, Hurst J, March ME, Bhoj EJ, Nowaczyk MJM, Gonzaga-Jauregui C, Mathew M, Dava-Wala S, Siemon A, Bartholomew D, Huang Y, Lee H, Martinez JA, Schwaibold EMC, Brunet T, Choukair D, Pais LS, White SM, Christodoulou J, Brown D, Lindstrom K, Grebe T, Tiosano D, Kayser MS, Tan TY, Deardorff MA, Song Y#, Hakonarson A. Pathogenic variants in SMARCA5, a chromatin remodeler, cause a range of syndromic neurodevelopmental features. Science Advances 2021 In press. #Co-corresponding authors. 2. Li F, Sami A, Noristani HN, Slattery K, Qiu J, Groves T, Wang S, Veerasammy K, Chen YX, Morales J, Hanes P, Sehgal A, He Y, Li S#, and Song Y#. Glial metabolic reprograming promotes axon regeneration and functional recovery in the central nervous system. Cell Metabolism 32(5): 767-785, November 2020. 3. Wang Q, Fan H, Li F, Sharum SR, Krishnamurthy V, Song Y#, Zhang K#. Optical control of ERK and AKT signaling promotes axon regeneration and functional recovery of PNS and CNS in Drosophila. eLife 9, October 2020. #Co-corresponding authors. 4. Muir AM, Cohen JL, Sheppard SE, Guttipatti P, Lo TY, Weed N, Doherty D, Fagerberg C, Kjærsgaard L, Larsen MJ, Wemmenhove-Lohner K, Hirsh Y, Zeevi DA, Zackai EH, Bhoj E, Song Y#, Mefford HC#. Bi-allelic Loss-of- Function Variants in NUP188 Cause a Recognizable Syndrome Characterized by Neurologic, Ocular, and Cardiaac Abnormalities. Am J Hum Genet. 106(5): 623-631, May 2020. #Co-corresponding authors. 5. Monahan Vargas EJ*, Matamoros AJ*, Qiu J*, Jan CH, Wang Q, Gorczyca D, Han TW, Weissman JS, Jan YN, Banerjee S and Song Y. The microtubule regulator ringer functions downstream from the RNA repair/splicing pathway to promote axon regeneration. Genes and Development 34(3-4): 194-208, February 2020. 6. Song Y#, Li D, Farrelly O, Miles L, Li F, Kim SE, Lo TY, Wang F, Li T, Thompson-Peer KL, Gong J, Murthy SE, Coste B, Yakubovich N, Patapoutian A, Yang X, Rompolas P, Jan LY, Jan YN#. The mechanosensitive ion channel Piezo inhibits axon regeneration. Neuron 102(2): 373-389, February 2019. #Co-corresponding authors. Successful candidates will benefit from the thriving and collegial UPenn/CHOP research community, tailored career development guidance, state-of-the-art research facilities and excellent benefits packages. Applicants should have a PhD and/or MD degree, and background in fly genetics, mammalian injury models or bioinformatics is highly recommended. Prospective applicants should send a brief statement of research, CV and the names and contact information of three references to Yuanquan Song at songy2@chop.edu. It is your accomplishment that leads to the success of the lab! Yuanquan Song, Ph.D. Assistant Professor, Department of Pathology & Laboratory Medicine Perelman School of Medicine, University of Pennsylvania The Raymond G. Perelman Center for Cellular and Molecular Therapeutics The Children's Hospital of Philadelphia Philadelphia, PA 19104 songy2@chop.edu |
| 1 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 家人們 調(diào)劑不迷路 看這里 +8 | likeihood 2026-03-09 | 10/500 |
|
|---|---|---|---|---|
|
[考研] 083000環(huán)境科學(xué)與工程調(diào)劑 +3 | mingmingry 2026-03-09 | 3/150 |
|
|
[考研] 一志愿天津大學(xué),英一數(shù)二305分求調(diào)劑,四六級已過 +5 | 小小番的茄 2026-03-09 | 5/250 |
|
|
[考研] 310 070300化學(xué)求調(diào)劑 +4 | 撲風(fēng)鈴的貓 2026-03-08 | 5/250 |
|
|
[考研] 085701環(huán)境工程專碩求調(diào)劑 +5 | 幼稚園大班打手 2026-03-08 | 5/250 |
|
|
[考研] 2026考研求調(diào)劑-材料類-本科211一志愿985-初試301分 +7 | 蟲友233 2026-03-07 | 7/350 |
|
|
[考研] 083000環(huán)境科學(xué)與工程調(diào)劑 +5 | 加油呀fxy 2026-03-07 | 6/300 |
|
|
[考研] 一志愿中科大能動297求調(diào)劑,本科川大 +4 | 邵11 2026-03-03 | 4/200 |
|
|
[考研] 288求調(diào)劑085600材料與化工 +13 | Daunrin 2026-03-07 | 15/750 |
|
|
[考研] 081700學(xué)碩一志愿北京化工大學(xué)數(shù)二英一過六級有競賽求調(diào)劑 +5 | galaxary 2026-03-07 | 7/350 |
|
|
[考研] 322分 085600求調(diào)劑,有互聯(lián)網(wǎng)+國金及主持省級大創(chuàng)經(jīng)歷 +4 | 熊境喆 2026-03-05 | 4/200 |
|
|
[考研] 一志愿武漢理工085601,初試301分,請問能調(diào)劑到湖北嗎 +3 | 肖yang 2026-03-06 | 3/150 |
|
|
[考研] 289求調(diào)劑 +3 | 馳光絕景 2026-03-04 | 4/200 |
|
|
[考研] 287求調(diào)劑 +3 | 看看我. 2026-03-05 | 6/300 |
|
|
[考研] 316求調(diào)劑 +3 | 林小星發(fā)大財 2026-03-05 | 5/250 |
|
|
[考研] 328求調(diào)劑 +6 | vuzhdkfjkx 2026-03-04 | 7/350 |
|
|
[考研] 考研282分求調(diào)劑,接受跨專業(yè) +4 | 劉淄博 2026-03-04 | 7/350 |
|
|
[考研] 271求調(diào)劑 +7 | 月色c 2026-03-05 | 8/400 |
|
|
[考研] 一志愿武理085601專碩347分求調(diào)劑 +4 | 啊歐歐歐 2026-03-04 | 5/250 |
|
|
[考研] 0703化學(xué)求調(diào)劑 +3 | 將未有期 2026-03-04 | 3/150 |
|